Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$1.54B
-
Value change
-
+$6.63M
-
Put/Call ratio
-
0.82
-
Number of buys
-
67
-
Number of sells
-
-56
-
Price
-
$10.94
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q1 2016
156 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q1 2016.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
of 162M outstanding shares and own 87.11% of the company stock.
Largest 10 shareholders include FMR LLC (19.1M shares), WELLINGTON MANAGEMENT GROUP LLP (17.8M shares), JANUS CAPITAL MANAGEMENT LLC (16.4M shares), ORBIMED ADVISORS LLC (11.6M shares), VANGUARD GROUP INC (9.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.71M shares), BlackRock Fund Advisors (5.53M shares), BRIDGER MANAGEMENT, LLC (5.18M shares), Consonance Capital Management LP (4.94M shares), and Redmile Group, LLC (4.32M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.